Evidence map›Paper›PMID 21540474›Full record

ReviewMolecular interventions2011

Spindle poisons and cell fate: a tale of two pathways.

Daniel R Matson, P Todd Stukenberg

Abstract readReview
In one paragraph

Review in Molecular interventions, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 135 citations in OpenAlex.

  1. Resolving paclitaxel efficacy.Nature chemical biology · 2026
    Article
  2. Review
  3. Critical Evaluation of Methods for the Identification of Aneugens.Environmental and molecular mutagenesis · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. NAR cancer · 2024
    Article
  8. Article
  9. On Drugs.The Journal of medicine and philosophy · 2023
    Article
  10. Anti-cancer effect ofRPS pharmacy and pharmacology reports · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Daniel R MatsonDepartment of Biochemistry and Molecular Genetics, University of Virginia Medical Center, Charlottesville, VA 22908, USA.
P Todd Stukenberg
University of Virginia Medical Center · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007267 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GARCIA-BLANCO, MARIANO A. · 1985 to 2024
$13.4M
TRAINING IN CELL AND MOLECULAR BIOLOGYT32GM008136 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI STUKENBERG, P. TODD · 1985 to 2020
$8.5M
Mechanisms of "End On" Microtubule Attachment by the KinetochoreR01GM081576 · NIGMS · UNIVERSITY OF VIRGINIA · PI STUKENBERG, P. TODD · 2008 to 2011
$1.2M
NIGMS NIH HHS 5R01GM081576-03NIGMS NIH HHS T32 GM007267NIGMS NIH HHS T32 GM007267-33NIGMS NIH HHS T32 GM008136NIGMS NIH HHS T32GM008136
6 · The paper itself

Abstract

Spindle poisons, such as paclitaxel and vinblastine, exert their potent anti-neoplastic effects through activation of the spindle assembly checkpoint (SAC), thereby arresting cells in mitosis. Unfortunately, only certain cancers are susceptible to these drugs, and many patients fail to respond to treatment. We review the pathways that are triggered by spindle poisons and highlight recent studies that describe the great variability of tumor cells in responding to these drugs. We also describe the recent identification of an apoptotic pathway that is activated by mitotic arrest in response to spindle poisons. Emerging from these studies is not only a greater understanding of how these classic antimitotic agents bring about cell death, but also a wealth of potential new targets of anticancer therapeutics.

Indexed as

Antimitotic AgentsApoptosisHumansMitosisMyeloid Cell Leukemia Sequence 1 ProteinNeoplasmsProto-Oncogene Proteins c-bcl-2Spindle ApparatusAntimitotic AgentsMyeloid Cell Leukemia Sequence 1 ProteinProto-Oncogene Proteins c-bcl-2

Identifiers

PMID21540474
PMCPMC3086919
OpenAlexW1963944756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.